Compounds > bemp phosphazene
Page last updated: 2024-12-10

bemp phosphazene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

BEMP phosphazene: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3513851
SCHEMBL ID185023
MeSH IDM0299792

Synonyms (32)

Synonym
2-tert-butylimino-2-diethylamino-1,3-diethyl-perhydro-1,3,2-diazaphosphorine
df15j146qi ,
unii-df15j146qi
bemp phosphazene
AKOS015894695
2-tert-butylimino-2-diethylamino-1,3-dimethyl-perhydro-1,3,2-diazaphosphorine
2-tert-butylimino-2-diethylamino-1,3-dimethylperhydro-1,3,2-diazaphosphorine
bemp
98015-45-3
2-(tert-butylimino)-n,n-diethyl-1,3-dimethyl-1,3,2lambda(5)-diazaphosphinan-2-amine
2-(tert-butylimino)-n,n-diethyl-1,3-dimethyl-1,3,2lambda5-diazaphosphinan-2-amine
2-t-butylimino-2-diethylamino-1,3-dimethyl-perhydro-1,3,2-diazaphosphorine
2-(tert-butylimino)-2-diethylamino-1,3-dimethylperhydro-1,3,2-diazaphosphorine
2-tert-butylimino-2-diethylamino-1,3-dimethyl-perhydro -1,3,2-diaza-phosphorine
VSCBATMPTLKTOV-UHFFFAOYSA-N
2-tert-butylimino-2-diethylamino-1,3-dimethyl-perhydro-1,3,2-diaza-phosphorine
2-tert-butylimino-2-diethylamino-1,3-dimethyl-1,3,2-diazaphosphorinane
2-tert.-butylimino-2-diethylamino-1,3-dimethylperhydro-1,3,2-diazaphosphorine
SCHEMBL185023
DTXSID50243369
2-tert-butylimino-2-diethylamino-1,3-dimethyl-perhydro-1,3,2-diazaphosphorin
mfcd00043143
2-tert-butylimino-2-diethylamino-1,3-dimethylperhydro-1,3,2-diazaphosphorine, purum, >=98.0% (gc)
BBL103546
STL557356
2-(tert-butylimino)-n,n-diethyl-1,3-dimethyl-1,3,2lambda~5~-diazaphosphinan-2-amine
FT-0730193
CS-0204484
2-tert-butylimino-n,n-diethyl-1,3-dimethyl-1,3,2lambda5-diazaphosphinan-2-amine
Q27276359
2-tert-butylimino-2-diethylamino-1,3-dimethylperhydro-1,3,2 diazaphosphorine
A915375
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's1 (16.67)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 13.13

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index13.13 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index5.08 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (13.13)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
ethylene
Plastipore: high density polyethylene sponge biocompatible material; used as posts in dental bridges		2.0810alkene;
gas molecular entity		plant hormone;
refrigerant
4-butyrolactone
4-Butyrolactone: One of the FURANS with a carbonyl thereby forming a cyclic lactone. It is an endogenous compound made from gamma-aminobutyrate and is the precursor of gamma-hydroxybutyrate. It is also used as a pharmacological agent and solvent.. tetrahydrofuranone : Any oxolane having an oxo- substituent at any position on the tetrahydrofuran ring.. gamma-butyrolactone : A butan-4-olide that is tetrahydrofuran substituted by an oxo group at position 2.		2.0710butan-4-olidemetabolite;
neurotoxin
propylene
propylene: structure		2.0810alkene;
gas molecular entity		refrigerant;
xenobiotic
beta-butyrolactone
beta-butyrolactone: structure		2.0710beta-lactone
alkenes
[no description available]		2.0810
t 1982
1,3,4,6,7,8-hexahydro-2H-pyrimido(1,2-a)pyrimidine: structure in first source		2.0710pyrimidines
1,8-diazabicyclo(5.4.0)undec-7-ene
[no description available]		2.0710
organophosphonates
hydrogenphosphite : A divalent inorganic anion resulting from the removal of a proton from two of the hydroxy groups of phosphorous acid.		2.0810divalent inorganic anion;
phosphite ion
ConditionIndicatedRelationship StrengthStudiesTrials